Evidence map›Paper›PMID 30853213›Full record

ArticleCell metabolism2019

LINE1 Derepression in Aged Wild-Type and SIRT6-Deficient Mice Drives Inflammation.

Matthew Simon, Michael Van Meter, Julia Ablaeva, Zhonghe Ke, Raul S Gonzalez, Taketo Taguchi, Marco De Cecco, Katerina I Leonova, Valeria Kogan, Stephen L Helfand and 10 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 344 papers.

0numbers the graph read from it
0cells of the map it votes in
344citing papers in PubMed
35.1field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

344 citing papers in PubMed, 484 citations in OpenAlex.

  1. Review
  2. Review
  3. Article
  4. Review
  5. Review
  6. Review
  7. Article
  8. Article
  9. Review
  10. The Hallmarks of Aging: From Molecular Mechanisms to Clinical Translation.International journal of molecular sciences · 2026
    Review
  11. AcutebioRxiv : the preprint server for biology · 2026
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Review
  18. Article
  19. Review
  20. LINE-1 Retrotransposons and Amyotrophic Lateral Sclerosis.International journal of molecular sciences · 2026
    Review

284 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 8 institutions in 2 countries.

Matthew SimonDepartment of Biology, University of Rochester, Rochester, NY 14627, USA.
Michael Van MeterDepartment of Biology, University of Rochester, Rochester, NY 14627, USA.
Julia AblaevaDepartment of Biology, University of Rochester, Rochester, NY 14627, USA.
Zhonghe KeDepartment of Biology, University of Rochester, Rochester, NY 14627, USA.
Raul S GonzalezDepartment of Pathology, University of Rochester Medical Center, Rochester, NY 14627, USA.
Taketo TaguchiDepartment of Biology, University of Rochester, Rochester, NY 14627, USA.
Marco De CeccoInstitute for Translational Research, Ariel University, Ariel, Israel.
Katerina I LeonovaDepartment of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Valeria KoganInstitute for Translational Research, Ariel University, Ariel, Israel.
Stephen L HelfandDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI 02912, USA.
Nicola NerettiDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI 02912, USA.
Asael RoichmanFaculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.
Haim Y CohenFaculty of Life Sciences, Bar-Ilan University, Ramat-Gan, Israel.
Margarita V MeerDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Vadim N GladyshevDivision of Genetics, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA 02115, USA.
Marina P AntochDepartment of Pharmacology and Therapeutics, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
Andrei V GudkovDepartment of Cell Stress Biology, Roswell Park Comprehensive Cancer Center, Buffalo, NY 14263, USA.
John M SedivyDepartment of Molecular Biology, Cell Biology and Biochemistry, Brown University, Providence, RI 02912, USA.
Andrei SeluanovDepartment of Biology, University of Rochester, Rochester, NY 14627, USA. Electronic address: andrei.seluanov@rochester.edu.
Vera GorbunovaDepartment of Biology, University of Rochester, Rochester, NY 14627, USA. Electronic address: vera.gorbunova@rochester.edu.
University of Rochester · USBrown University · USRoswell Park Comprehensive Cancer Center · USAriel University · ILBar-Ilan University · ILBrigham and Women's Hospital · USHarvard University · USUniversity of Rochester Medical Center · US

Funding

The role of hyaluronan in longevity and cancer resistance of longest-lived rodentP01AG047200 · NIA · UNIVERSITY OF ROCHESTER · PI Andrei Seluanov · 2014 to 2026
$36.9M
Somatic Activation of Retrotransposition: A New Molecular Mechanism of Aging?P01AG051449 · NIA · BROWN UNIVERSITY · PI John M Sedivy · 2016 to 2026
$30.4M
The role of SIRT6 posttranslational modifications in aging and genome stability. Supplement: Testing SIRT6 activators as potential Alzheimer's disease therapy.R01AG027237 · NIA · UNIVERSITY OF ROCHESTER · PI Vera Gorbunova · 2006 to 2026
$6.2M
Regulation of epigenome stability by SIRT6 during aging. Supplement: Does centenarian variant of SIRT6 or bowhead whale SIRT6 confer protection from Alzheimer's disease?R37AG046320 · NIA · UNIVERSITY OF ROCHESTER · PI Andrei Seluanov · 2019 to 2026
$4.7M
Mechanisms of lifespan controlDP1AG047745 · NIA · BRIGHAM AND WOMEN'S HOSPITAL · PI GLADYSHEV, VADIM N. · 2013 to 2018
$4.4M
Effectors of cellular senescence statesR37AG016694 · NIA · BROWN UNIVERSITY · PI SEDIVY, JOHN M · 2009 to 2018
$3.2M
Regulation of genome stability by SITR6R01AG046320 · NIA · UNIVERSITY OF ROCHESTER · PI SELUANOV, ANDREI · 2014 to 2018
$1.9M
Repressing Retrotransposon LINE-1: New Concepts for Osteoarthritis TreatmentR61AR076807 · NIAMS · RHODE ISLAND HOSPITAL · PI CHEN, QIAN · 2019 to 2020
$1.2M
NIAMS NIH HHS R61 AR076807NIA NIH HHS DP1 AG047745NIA NIH HHS P01 AG047200NIA NIH HHS P01 AG051449NIA NIH HHS R01 AG027237NIA NIH HHS R01 AG046320NIA NIH HHS R37 AG016694NIA NIH HHS R37 AG046320
6 · The paper itself

Abstract

Mice deficient for SIRT6 exhibit a severely shortened lifespan, growth retardation, and highly elevated LINE1 (L1) activity. Here we report that SIRT6-deficient cells and tissues accumulate abundant cytoplasmic L1 cDNA, which triggers strong type I interferon response via activation of cGAS. Remarkably, nucleoside reverse-transcriptase inhibitors (NRTIs), which inhibit L1 retrotransposition, significantly improved health and lifespan of SIRT6 knockout mice and completely rescued type I interferon response. In tissue culture, inhibition of L1 with siRNA or NRTIs abrogated type I interferon response, in addition to a significant reduction of DNA damage markers. These results indicate that L1 activation contributes to the pathologies of SIRT6 knockout mice. Similarly, L1 transcription, cytoplasmic cDNA copy number, and type I interferons were elevated in the wild-type aged mice. As sterile inflammation is a hallmark of aging, we propose that modulating L1 activity may be an important strategy for attenuating age-related pathologies.

Indexed as

Age FactorsAnimalsDideoxynucleotidesFemaleInflammationMaleMiceMice, Inbred StrainsMice, KnockoutRNA-Binding ProteinsSirtuinsStavudineThymine NucleotidesZidovudineDideoxynucleotidesECAT11 protein, mouseRNA-Binding ProteinsSirt6 protein, mouseSirtuinsStavudineThymine NucleotidesZidovudinezidovudine triphosphateaginglongevitynucleotide reverse-transcriptase inhibitorsretrotranspositionSIRT6

Identifiers

PMID30853213
PMCPMC6449196
OpenAlexW2921681769

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.